CellWell record HH-76646
Clinical Utility of SARS-CoV-2 Antibody Titers in the Management of Patients With Long COVID Infected With the Omicron Variant
Marina Kawaguchi; Yasue Sakurada; Kazuki Tokumasu; Yuki Otsuka; Yasuhiro Nakano; Yui Matsuda; Hiroyuki Honda; Daisuke Omura; Nobuyoshi Matsuki; Masanori Furukawa; Akihito Higashikage; Fumio Otsuka
2026
In plain language
Among 275 patients with Omicron-related long COVID, low spike antibody titers were associated with memory impairment and reduced quality of life, while nucleocapsid titers tracked acute disease severity.
- Evidence
- Emerging
Cite this record: https://thecellwell.org/studies/HH-76646
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.